Angiodynamics Inc (ANGO): who owns it and who trades it
As of Nov 16, 2026, ANGO insiders reported 3 open-market sales worth $655K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Warren Nighan JR (Vice president), with $344K. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Angiodynamics
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns ANGO
162 funds and institutions reported ANGO shares worth $502M at the end of Q2 2026, about 94% of the company. The largest holder is BlackRock, Inc. with 9.2%.
Funds and institutions (13F) 94%Everyone else 6%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 3.80M | 9.20% | $49.5M | +3% |
| Point72 Asset Management, L.P. | 3.06M | 7.41% | $39.8M | -4% |
| Systematic Financial Management LP | 2.64M | 6.39% | $34.3M | +8% |
| Armistice Capital, LLC | 2.20M | 5.32% | $28.6M | +18% |
| Royce & Associates LP | 1.97M | 4.77% | $25.6M | +29% |
| Broadfin Holdings LLC | 1.82M | 4.40% | $23.7M | -12% |
| Vanguard Capital Management LLC | 1.69M | 4.10% | $22M | -2% |
| Weber Capital Management LLC | 1.36M | 3.28% | $17.6M | -1% |
| Nuveen, LLC | 1.20M | 2.90% | $15.6M | -1% |
| Geode Capital Management, LLC | 1.02M | 2.47% | $13.3M | +4% |
| Dimensional Fund Advisors LP | 969,497 | 2.35% | $12.6M | +2% |
| State Street Corp | 958,167 | 2.32% | $12.5M | -28% |
| Segall Bryant & Hamill, LLC | 926,711 | 2.24% | $12.1M | -4% |
| Bastion Asset Management Inc. | 923,270 | 2.23% | $10.8M | -30% |
| Pier Capital, LLC | 806,678 | 1.95% | $10.5M | +1% |
| Millennium Management LLC | 783,125 | 1.90% | $10.2M | +21% |
| Renaissance Technologies LLC | 733,883 | 1.78% | $9.5M | -9% |
| Arrowstreet Capital, Limited Partnership | 692,534 | 1.68% | $9M | -9% |
| Paradigm Capital Management Inc | 671,200 | 1.62% | $8.7M | -7% |
| AQR Capital Management LLC | 589,157 | 1.43% | $7.7M | +134% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ANGO insiders reported $0 of open-market purchases and $655K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Stephen A Trowbridge | CFO | Sale | 23,615 | $12.27 | $290K | Form 4 |
| Oct 28, 2026 | Stephen A Trowbridge | CFO | Sale | 1,720 | $12.17 | $20.9K | Form 4 |
| Jul 30, 2026 | Warren Nighan JR | Vice president | Sale | 23,370 | $14.72 | $344K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Warren Nighan JR | SVP Quality and Regulatory | – | $344K | Jul 30, 2026 |
| Stephen A Trowbridge | EVP and CFO | – | $311K | Oct 29, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ANGO short interest
Low short interest. 4.8% of ANGO shares are sold short: about 1 share in 21. Over the last 12 reports the number of shares short went up 3%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 2.00M ANGO shares were sold short, 4.8% of the shares outstanding, up 4.5% from the report before. At the average daily volume of 686,981 shares, buying them all back would take about 2.9 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 2.00M | 4.76% | +5% | 686,981 | 2.9 |
| Oct 15, 2026 | 1.92M | 4.56% | +48% | 1.31M | 1.5 |
| Sep 30, 2026 | 1.29M | 3.13% | -4% | 581,401 | 2.2 |
| Sep 15, 2026 | 1.34M | 3.25% | -1% | 385,990 | 3.5 |
| Aug 31, 2026 | 1.36M | 3.30% | +1% | 252,467 | 5.4 |
| Aug 14, 2026 | 1.35M | 3.27% | +11% | 552,547 | 2.5 |
| Jul 31, 2026 | 1.22M | 2.96% | -7% | 485,094 | 2.5 |
| Jul 15, 2026 | 1.32M | 3.18% | -3% | 592,146 | 2.2 |
| Jun 30, 2026 | 1.36M | 3.29% | -23% | 469,575 | 2.9 |
| Jun 15, 2026 | 1.76M | 4.25% | -7% | 288,475 | 6.1 |
| May 29, 2026 | 1.89M | 4.57% | -3% | 310,669 | 6.1 |
| May 15, 2026 | 1.95M | 4.72% | -6% | 278,529 | 7.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded ANGO
Since Nov 17, 2024, 1 member of Congress reported 1 purchase and 2 sales of ANGO. The latest was a sale by Debbie Wasserman Schultz on Oct 20, 2025, reported Oct 24, 2025.
Purchases 1Sales 2
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Oct 20, 2025 | Debbie Wasserman Schultz (D-FL) | Sale | $2K | Child | Oct 24, 2025 | Report |
| Jul 16, 2025 | Debbie Wasserman Schultz (D-FL) | Sale | $1K–$15K | Self | Jul 25, 2025 | Report |
| Jun 27, 2025 | Debbie Wasserman Schultz (D-FL) | Purchase | $1K–$15K | Child | Jul 25, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Angiodynamics company events
Angiodynamics filed 8 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 8, 2026.
- Oct 8, 2026ResultsReleased financial results. Filing
- Oct 8, 2026LeadershipBelow, which is incorporated by reference into this Item 1.01. Filing
- Jul 14, 2026ResultsReleased financial results. Filing
- Apr 23, 2026AnnouncementAngioDynamics, Inc. filed a complaint commencing a patent infringement lawsuit in the United States District Court for the District of Delaware against Endovascular Engineering, Inc. Filing
- Apr 2, 2026ResultsReleased financial results. Filing
- Feb 3, 2026LeadershipIn connection with James C. Clemmer’s previously announced intention to retire from his position as President and Chief Executive Officer of AngioDynamics, Inc. and its subsidiaries (together, the “ Company Group ”), the Company and Mr. Clemmer entered into a Transition and Retirement Agreement… Filing
- Jan 14, 2026AnnouncementShared information with investors. Filing
- Jan 6, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Angiodynamics financials
Famous investors that hold ANGO
4 of the 50 well-known investors we track reported holding ANGO in their latest 13F filing. The largest position is Steve Cohen's, worth $14.8M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 964,953 | $14.8M | 0.0% | -68% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 620,383 | $9.5M | 0.0% | -15% |
| Israel Englander · Millennium Management | Q3 2026 | 522,226 | $8M | 0.0% | -33% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 67,392 | $1M | 0.0% | +440% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named ANGO in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Point72 Asset Management, L.P. | 13G/A | 2.3% |
| Nov 16, 2026 | Point72 Asset Management, L.P. | 13G/A | 2.3% |
Questions about Angiodynamics Inc (ANGO) stock
Who owns the most ANGO stock?
The largest reported owner of Angiodynamics Inc (ANGO) is BlackRock, Inc., with 9.2% of the company. In total, 162 funds and institutions reported holding ANGO at the end of Q2 2026, together about 94% of the shares. See the largest owners.
Are ANGO insiders buying or selling?
In the last 12 months, ANGO insiders reported no open-market purchases and 3 sales worth $655K. The latest trade was on Oct 29, 2026. See every trade.
What is the short interest in ANGO?
As of Oct 30, 2026, 2.00M ANGO shares were sold short, 4.8% of the shares outstanding, up 4.5% from the report before. At the average daily volume of 686,981 shares, buying them all back would take about 2.9 trading days (days to cover). See the history.
Have members of Congress traded ANGO?
Yes. 1 member of Congress reported 1 purchase and 2 sales of ANGO since Nov 17, 2024. The latest was reported on Oct 24, 2025. See the trades.
Which famous investors hold ANGO?
4 of the 50 well-known investors we track reported ANGO in their latest 13F filing, including Steve Cohen, Jim Simons, Israel Englander. The largest position is worth $14.8M. See all holders.
Executive pay
Angiodynamics's chief executive was paid a total of $6.1M for the year ended May 31, 2026, up 10% from $5.5M the year before. In the last 12 months, Angiodynamics's executives and directors bought no stock on the open market and sold $655K.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.